July 26, 2016 12:40 PM ET


Company Overview of Praecis Pharmaceuticals Inc.

Company Overview

As of February 16, 2007, Praecis Pharmaceuticals Inc. was acquired by GlaxoSmithKline plc. Praecis Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery and development of novel compounds to address unmet medical needs or improve existing therapies. The company focuses on a drug discovery technology, DirectSelect, which enables the generation and practical use of ultra-large libraries for the discovery of orally active compounds for drug development. The company also focuses its research and development efforts on PPI-2458, an oral compound targeted at the inhibition of the enzyme methionine aminopeptidase type 2, which is in clinical development for cancer indications,...

830 Winter Street

Waltham, MA 02451-1420

United States

Founded in 1993

75 Employees





Key Executives for Praecis Pharmaceuticals Inc.

Praecis Pharmaceuticals Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Praecis Pharmaceuticals Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.